Herbpon is a E-Commerce Based Discount Marketplace for the Cannabinoid Industry | CashCropToday
0 Shares 1942 Views

Herbpon is a E-Commerce Based Discount Marketplace for the Cannabinoid Industry

June 14, 2018
1942 Views

Herbpon is a new company based out of San Diego, California that operates a digital commerce based marketplace directly promoting discounted goods and services centered around the medical and recreational cannabinoid market.

Herbpon partners directly with dispensaries, retail stores, recreational cannabis shops, and other related companies to market and offer a wide range of goods and services to consumers and vacationers around the city.

The company offers individuals the ability to search through, find deals, purchase, and redeem their deals through their website Herbpon.com. In todays marketplace convenience is the key when discussing a merchant and customer relationship. Herbpon offers a unique service for retail outlets to advertise their discounted goods to locals in San Diego in a convenient and straightforward manner.

The focus is to offer their customers the ability to find discounts on products that include daily deals associated with local medical or recreational dispensary, hemp derived CBD products, high quality glassware, rolling papers, grinders, doctors recommendations, and a number of different types of goods and services.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
278 views
Market Watch
278 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
196 views
Global
196 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
193 views
Manufacturing
193 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: